News and Trends 21 Jul 2022
Vicebio exits stealth to work on next generation RSV vaccine
Vicebio Ltd, a biopharmaceutical company founded by Medicxi in 2019, has launched to accelerate the development of novel vaccines against life-threatening respiratory viral infections using its molecular clamp technology platform. The technology has been developed by Paul Young, Daniel Watterson, Keith Chappell and their groups at The University of Queensland (UQ), Brisbane, Australia. It was […]
